Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines.
Pathology in most chronic inflammatory diseases is characterized by an imbalance in cytokine expression. Targeting cytokines with monoclonal antibodies has proven to be a highly effective treatment. However, monoclonal antibody therapy has disadvantages such as high production costs, generation of a...
Main Authors: | Link, A, Bachmann, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Immunodrugs: therapeutic VLP-based vaccines for chronic diseases.
by: Jennings, G, et al.
Published: (2009) -
Anticytokine Autoantibodies and Fungal Infections
by: Shanthi Kappagoda, et al.
Published: (2023-07-01) -
Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation
by: Vijaya Knight, et al.
Published: (2016-01-01) -
CLINICAL EXAMPLES OF ANTICYTOKINE TREATMENT OF CHILDREN WITH CROHN DISEASE
by: M.M. Venediktova, et al.
Published: (2011-09-01) -
CLINICAL EXAMPLES OF ANTICYTOKINE TREATMENT OF CHILDREN WITH CROHN DISEASE
by: M.M. Venediktova, et al.
Published: (2011-01-01)